Concepedia

Lawrence V. Friedrich

LV

Statistics

Publications

41

Citations

2.3K

H-Index

26

Active since

1990

Affiliations

Medical University of South Carolina(Current)

Cubist Pharmaceuticals (United States)

Institute for Clinical Pharmacodynamics (United States)

JMI Laboratories

University of Oxford

Lawrence V. Friedrich is an author at Medical University of South Carolina specializing in pharmacology, antimicrobial pharmacotherapy, and medicine.

Publications per year

1990–2023

41

Publications

41

Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicillin-resistant S. aureus (MRSA) blood isolates from 2001 05

Gregory E. Steinkraus, Roger L. White, Lawrence V. Friedrich · Journal of Antimicrobial Chemotherapy · 2007 · 421 citations · Full text

, , +17

Comparison of methods of interpretation of checkerboard synergy testing

Charles R. Bonapace, John A. Bosso, Lawrence V. Friedrich et al. · Diagnostic Microbiology and Infectious Disease · 2002 · 197 citations

, , +4

Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods

Charles R. Bonapace, Roger L. White, Lawrence V. Friedrich et al. · Diagnostic Microbiology and Infectious Disease · 2000 · 159 citations

, , +13

Clinical Experience with Daptomycin for the Treatment of Patients with Osteomyelitis

Kenneth C. Lamp, Lawrence V. Friedrich, Luke Mendez-Vigo et al. · The American Journal of Medicine · 2007 · 106 citations

, , +12

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Ceftolozane in an <i>In Vitro</i> Infection Model

Brian VanScoy, Rodrigo E. Mendes, Anthony M. Nicasio et al. · Antimicrobial Agents and Chemotherapy · 2013 · 105 citations · Full text

, , +17

1–5 of 41